---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-060090"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T12:46:30.659902+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics issues Series F Preferred Stock to Chairman with 50M votes per share on reverse split proposals

## Summary
- Issued one share of Series F Preferred Stock to Chairman Richard J. Hawkins for $1,000 cash.
- Preferred stock carries 50,000,000 votes per share, voting only on reverse stock split proposals in proportion to common stock votes.
- No conversion rights, no dividends, no liquidation preference; redeemable at board discretion or automatically upon stockholder approval of reverse split.
- Issuance exempt from registration under Rule 506 of Regulation D.
- Certificate of Designation filed with Delaware Secretary of State on March 3, 2023.

## SEC filing metadata
- accession: 0001193125-23-060090
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312523060090/0001193125-23-060090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312523060090/d449434d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-060090
- JSON: https://secwatch.observer/filing/0001193125-23-060090.json
- Plain text: https://secwatch.observer/filing/0001193125-23-060090.txt

## Key facts
- Governance Changes
  PLUS THERAPEUTICS, INC.: Filed a certificate of designation for Preferred Stock with specific voting rights and redemption provisions (effective 2023-03-03).
  - Change: charter amendment
  - Effective: 2023-03-03
  source text: On March 3, 2023, the Company filed a certificate of designation (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312523060090/0001193125-23-060090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.